Statement of changes against current valued financial instruments deducted from available reserves

NameChangesInCurrentValueOfFinancialInstrumentsDeductedFromAvailableReservesMember
Namespacehttp://www.nltaxonomie.nl/nt17/jenv/20221214.a/dictionary/jenv-bw2-domains
Prefixjenv-bw2-dm
Data typexbrli:stringItemType
Period typeduration
Substitution Groupsbr:domainMemberItem
BalanceNone
NillableFalse
AbstractTrue

Labels

TextLangRoleContainer role
Angabe zu Wertveränderungen von Finanzinstrumenten, die mit dem Zeitwert bewertet werden, und die zu Lasten der freien Reserven aktiviert wurdendehttp://www.xbrl.org/2003/role/labelhttp://www.xbrl.org/2003/role/link
Statement of changes against current valued financial instruments deducted from available reservesenhttp://www.xbrl.org/2003/role/labelhttp://www.xbrl.org/2003/role/link
Déclaration des changements de valeur des instruments financiers évalués à la valeur actuelle déduite des réserves disponiblesfrhttp://www.xbrl.org/2003/role/labelhttp://www.xbrl.org/2003/role/link
Opgave waardeveranderingen van tegen actuele waarde gewaardeerde financiële instrumenten welke op de vrije reserves in mindering zijn gebrachtnlhttp://www.xbrl.org/2003/role/labelhttp://www.xbrl.org/2003/role/link

References

NameValueRole
Article381ahttp://www.xbrl.org/2003/role/reference
IssueDate2021-01-01http://www.xbrl.org/2003/role/reference
NameBurgerlijk wetboek boek 2http://www.xbrl.org/2003/role/reference
Paragraphbhttp://www.xbrl.org/2003/role/reference
ChapterB12http://www.xbrl.org/2003/role/reference
IssueDate2021-01-01http://www.xbrl.org/2003/role/reference
NameRichtlijnen voor de jaarverslaggeving voor kleine rechtspersonenhttp://www.xbrl.org/2003/role/reference
Paragraph110http://www.xbrl.org/2003/role/reference

Related Parent Concepts

NameRelation TypeRole
jenv-bw2-i:ChangesInCurrentValueOfFinancialInstrumentsDeductedFromAvailableReserves
ConceptMemberEquivalencehttp://www.xbrl.org/2008/role/link
rj-abstr:AnnualReportingGuidelinesB12Title
parent-childurn:rj:linkrole:annual-reporting-guidelines-b12